Author:
Zvyagintseva T.D., ,Chernobay A.I.,Yaroshenko A.V.,Oparin A.G., , ,
Abstract
In the article, from the modern standpoint, the pathogenetic and clinical characteristics of PCS as a dysfunction of the sphincter of Oddi are given, the mechanisms for the development of this pathology, the principles of therapy with the inclusion of the drug Rowachol, containing six plant monoterpenes, are disclosed. The materials of our own observations of the treatment of patients with Oddi sphincter dysfunction after laparoscopic cholecystectomy by Rowachol are presented. Anti-inflammatory, litholytic, hypocholesterolemic and pleiotropic effects of Rowachol have been proved. Rowachol should be positioned as a pathogenetic natural remedy for treatment of Oddi sphincter dysfunction and biliary sludge in patients undergoing cholecystectomy for cholelithiasis.
Publisher
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
Reference32 articles.
1. 1. Bordin DS, Dubcova EA, Selezneva JeJa. Jeffektivnost' i bezopasnost' razlichnyh doz gemikronoma u bol'nyh, perenesshih holecistjektomiju. Jeffektivnaja farmakoterapija. 2021;3:34-39. Russian
2. 2. Bystrovskaja E.V. Postholecistjektomicheskij sindrom: patogeneticheskie i terapevticheskie aspekty problem. remedium.ru. Russian
3. 3. Bueverov AO. Disfunkcija sfinktera Oddi v postholecistjektomicheskom periode. Medicinskij sovet. 2020;15:90-95. doi: 10.21518/2079-701X2020-15-90-95. Russian
4. 4. Zvjaginceva TD, Chernobaj AI. Patogeneticheskaja korrekcija biliarnoj boli pri postholecistjektomicheskom sindrome i disfunkcii sfinktera Oddi. Suchasna gastroenterologіja. 2012;6(68):81-92. Russian
5. 5. Zviahintseva TD, Serhiienko OI, Chernobai AI. Funktsionalni zakhvoriuvannia biliarnoi systemy. Funktsionalni zakhvoriuvannia orhaniv travlennia. Kharkiv: Tochka; 2010. Р 35-70. Ukrainian